Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39,536 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bendamustine in the treatment of patients with indolent non-Hodgkin lymphoma refractory or relapse to rituximab treatment: An open-label, single-agent, multicenter study in China.
Gao Y, Liu Y, Wang Y, Zhang Q, Wu D, Ye X, Wu J, Xu W, Zhou J, Yang Y, Cen H, Zhang F, Xiang Y, Tang X, Ding K, Lin J, Ma L, Wang S, Yu H, Zhao Y, Song B, Lv F, Huang H. Gao Y, et al. Among authors: yu h. Cancer. 2023 Feb 15;129(4):551-559. doi: 10.1002/cncr.34544. Epub 2022 Dec 21. Cancer. 2023. PMID: 36541221 Free article.
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial.
Xu RH, Shen L, Wang KM, Wu G, Shi CM, Ding KF, Lin LZ, Wang JW, Xiong JP, Wu CP, Li J, Liu YP, Wang D, Ba Y, Feng JP, Bai YX, Bi JW, Ma LW, Lei J, Yang Q, Yu H. Xu RH, et al. Among authors: yu h. Chin J Cancer. 2017 Dec 22;36(1):97. doi: 10.1186/s40880-017-0263-y. Chin J Cancer. 2017. PMID: 29273089 Free PMC article. Clinical Trial.
Anlotinib vs placebo as third- or further-line treatment for patients with small cell lung cancer: a randomised, double-blind, placebo-controlled Phase 2 study.
Cheng Y, Wang Q, Li K, Shi J, Liu Y, Wu L, Han B, Chen G, He J, Wang J, Lou D, Yu H, Wang S, Qin H, Li X. Cheng Y, et al. Among authors: yu h. Br J Cancer. 2021 Aug;125(3):366-371. doi: 10.1038/s41416-021-01356-3. Epub 2021 May 18. Br J Cancer. 2021. PMID: 34006926 Free PMC article. Clinical Trial.
Eliciting national and subnational sets of disability weights in mainland China: Findings from the Chinese disability weight measurement study.
Liu X, Wang F, Yu C, Zhou M, Yu Y, Qi J, Yin P, Yu S, Zhou Y, Lin L, Liu Y, Wang Q, Zhong W, Huang S, Li Y, Liu L, Liu Y, Ma F, Zhang Y, Tian Y, Yu Q, Zeng J, Pan J, Zhou M, Kang W, Zhou JY, Yu H, Liu Y, Li S, Yu H, Wang C, Xia T, Xi J, Ren X, Xing X, Cheng Q, Fei F, Wang D, Zhang S, He Y, Wen H, Liu Y, Shi F, Wang Y, Sun P, Bai J, Wang X, Shen H, Ma Y, Yang D, Mubarik S, Cao J, Meng R, Zhang Y, Guo Y, Yan Y, Zhang W, Ke S, Zhang R, Wang D, Zhang T, Nomura S, Hay SI, Salomon JA, Haagsma JA, Murray CJL, Vos T. Liu X, et al. Among authors: yu q, yu c, yu s, yu h, yu y. Lancet Reg Health West Pac. 2022 Jul 26;26:100520. doi: 10.1016/j.lanwpc.2022.100520. eCollection 2022 Sep. Lancet Reg Health West Pac. 2022. PMID: 35910433 Free PMC article.
39,536 results
You have reached the last available page of results. Please see the User Guide for more information.